Naltrexone is one of several new medications (the others are topirimate and acamprosate) that has been shown to reduce the risk of relapse in people with alcohol use disorders. But naltrexone is used relatively rarely for this purpose. A new study suggests that it may be possible to predict which patients are especially likely to respond to naltrexone treatment. The …